ENTA
Enanta Pharmaceuticals Inc
Price:  
13.43 
USD
Volume:  
105,933.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ENTA Probability of Bankruptcy

The Probability of Bankruptcy of Enanta Pharmaceuticals Inc (ENTA) is 13.00% . This number represents the probability that ENTA will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating ENTA's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

ENTA - ESG ratings

ESG ratings are directly linked to the cost of capital and ENTA's ability to raise funding, both of which can significantly affect the probability of Enanta Pharmaceuticals Inc going bankrupt.

ESG Score 71.37
Environment Score 76.13
Social Score 81.49
Governance Score 56.50
Returns
Historical Returns (5 day) 4.03%
Historical Returns (MTD) 7.70%
Historical Returns (YTD) 42.72%
Historical Returns (13 week) -6.99%
Historical Returns (26 week) 41.67%
Historical Returns (52 week) -43.57%
Efficiency
Asset Turnover 0.16
Receiveable Turnover 5.70
Gross Margin
Operating Margin -192.13%
Pretax Margin -184.82%
Net Margin -182.70%
Return on Asset (ROA) -29.28
Return on Equity (ROE) -64.86
Return on Investments (ROI) -64.41
Price Metrics
Market Cap (M) 284.45
Enterprise Value (M)
52 Week High 25.08
52 Week Low 8.08
Beta 0.99
Average Volume (10 day) 0.04
Average Volume (3 month) 0.06
Price / Earnings (P/E)
Price / Sales (P/S) 3.87
Earnings
EPS -6.25
Revenue CAGR (5 year) -17.45%
Risk
Current Ratio 6.43
Quick Ratio 6.23